United Imaging announces multiple partnerships in Middle East and Africa

At Arab Health 2023 in Dubai, China-based firm United Imaging has forged a partnership agreement with I-ONE Nuclear Medicine & Oncology Center for a collaboration and research agreement for the first PET/MR uPMR 790 in the gulf countries.

I-ONE Nuclear Medicine & Oncology Center is regarded as the first research facility of its kind in Saudi Arabia's western area. United Imaging and I-ONE's agreement establishes a research academy for advanced PET/MR imaging, especially neuro and cardiac PET. The two companies will explore clinical applications and education about the value of artificial intelligence (AI), digital PET/MR, low-dose PET imaging, small lesion early detection, and new tracers.

Arab Health also marked the signing of an agreement between United Imaging and My Doctor Medical Center, a leading private hospital in Qatar that chose United Imaging's full solution suite, including high-end 1.5T MRI, cardiac CT and digital X-ray. The two organisations will cooperate on cutting-edge technologies like fast MRI imaging and low-dose CT imaging.

United Imaging also announced a package agreement with Health Garden Clinic that included the installation of the first uMR680, the most advanced wide bore 1.5T MRI, in Morocco. Dedicated to cardiac and pediatric imaging and women's health, this clinic will bring together the best radiology practice in Rabat, Morocco to benefit patients in the region.

The Middle East and Africa have traditionally been among United Imaging's important overseas markets. During Arab Health 2023, United Imaging also strengthened cooperation with one of the Top 5 medical product suppliers in Saudi Arabia, Cigalah, and another top player in the Diagnostic Imaging Industry in Kazakhstan, Tengri LLC, to boost its expansion in the Middle East and accelerate development in Central Asia.

Currently, over 10,400 hospitals and research institutions in 59 countries and regions are using more than 22,900 United Imaging products in clinical settings, including China, the US, the Middle East, Europe, Japan, India, Southeast Asia, Africa, and South America.